ZEB1 and pancreatic neoplasm: Isoflavone treatment increased the expression of miR-200b, miR-200c, miR-let-7b, miR-let-7c, miR-let-7d, and miR-let-7e resulting in reduced levels of their target proteins zinc finger E-box-binding homeobox 1 (ZEB1) and vimentin in pancreatic cancer cells (Li et al., 2009).